Transcriptome of Male Breast Cancer Matched with Germline Profiling Reveals Novel Molecular Subtypes with Possible Clinical Relevance.
BRCA1/2
germline mutations
male breast cancer
molecular subtypes
transcriptome profiling
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
08 Sep 2021
08 Sep 2021
Historique:
received:
30
07
2021
revised:
30
08
2021
accepted:
01
09
2021
entrez:
28
9
2021
pubmed:
29
9
2021
medline:
29
9
2021
Statut:
epublish
Résumé
Male breast cancer (MBC) is a rare and understudied disease compared with female BC. About 15% of MBCs are associated with germline mutation in BC susceptibility genes, mainly
Identifiants
pubmed: 34572741
pii: cancers13184515
doi: 10.3390/cancers13184515
pmc: PMC8469418
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Associazione Italiana per la Ricerca sul Cancro
ID : IG2018-21389
Organisme : Lega italiana per la lotta contro i tumori (LILT)
ID : IG2019
Organisme : Ministero dell'Istruzione, dell'Università e della Ricerca
ID : Dipartimenti di Eccellenza-L. 232/2016
Références
J Natl Cancer Inst Monogr. 2011;2011(43):79-81
pubmed: 22043047
Mol Clin Oncol. 2020 Feb;12(2):120-125
pubmed: 31929882
Breast Cancer Res Treat. 2012 Jul;134(1):411-8
pubmed: 22527108
Int J Cancer. 2019 Jul 15;145(2):390-400
pubmed: 30613976
Breast Cancer Res Treat. 2017 Feb;161(3):575-586
pubmed: 28008555
J Cell Biochem. 2019 Jan;120(1):575-583
pubmed: 30125992
Nat Rev Cancer. 2014 Oct;14(10):643
pubmed: 25379579
Breast Cancer Res Treat. 2018 May;169(1):105-113
pubmed: 29335925
Oncotarget. 2017 Apr 4;8(14):23937-23954
pubmed: 28147341
PLoS One. 2014 Jan 16;9(1):e78644
pubmed: 24454679
NPJ Breast Cancer. 2021 Jul 26;7(1):98
pubmed: 34312396
Bioinformatics. 2006 Jun 15;22(12):1540-2
pubmed: 16595560
Front Oncol. 2020 Apr 28;10:570
pubmed: 32457830
Mol Clin Oncol. 2019 Jun;10(6):644-654
pubmed: 31031981
Oncol Res Treat. 2017;40(4):167-172
pubmed: 28376490
Eur J Cancer. 2017 Sep;82:219-227
pubmed: 28292559
Appl Clin Genet. 2011 Nov 14;4:145-58
pubmed: 23776375
Clin Cancer Res. 2008 Aug 15;14(16):5158-65
pubmed: 18698033
BMC Med Genomics. 2014 Jan 31;7:9
pubmed: 24479546
Breast Cancer Res Treat. 2019 Jan;173(1):37-48
pubmed: 30267249
Clin Cancer Res. 2017 May 15;23(10):2575-2583
pubmed: 27986751
Breast Cancer Res. 2016 Feb 09;18(1):15
pubmed: 26857456
BMC Bioinformatics. 2013;14 Suppl 9:S1
pubmed: 23902433
Endocr Relat Cancer. 2019 Oct;26(10):779-794
pubmed: 31340200
J Clin Oncol. 2020 Jun 1;38(16):1849-1863
pubmed: 32058842
Cold Spring Harb Protoc. 2017 Mar 1;2017(3):
pubmed: 27574194
Breast Cancer Res. 2012 Feb 14;14(1):R31
pubmed: 22333393
Cancer. 2017 Jan 1;123(2):210-218
pubmed: 27648926
Breast Cancer Res. 2004;6(3):R252-63
pubmed: 15084249
Breast. 2018 Aug;40:85-91
pubmed: 29709729
Curr Med Chem. 2012;19(23):3907-21
pubmed: 22788767
Breast Cancer Res Treat. 2011 Jun;127(3):601-10
pubmed: 20625818
Nat Med. 2018 May;24(5):541-550
pubmed: 29686425
J Natl Cancer Inst. 2015 Feb 23;107(5):
pubmed: 25713166
Breast. 2018 Apr;38:92-97
pubmed: 29287190
N Engl J Med. 2018 Jun 14;378(24):2311-2320
pubmed: 29897847
J Clin Oncol. 2010 Oct 1;28(28):4307-15
pubmed: 20697084
N Engl J Med. 2008 Mar 27;358(13):1409-11
pubmed: 18367751